U.S. Tobacco Stock News

Currency markets are back in the spotlight after US and Japanese authorities moved to support the yen and rattled global equities. A stronger US dollar can quietly reshape winners and losers, especially for companies with overseas cost bases or import heavy models. This article walks through three stocks from our US Dollar Beneficiaries screener that appear positioned to feel the impact, so you can decide whether they deserve a spot on your watchlist. The stocks covered below are just a...

Trade Desk (NasdaqGM:TTD) reported Q2 2026 revenue growth of 3%, which stalled relative to prior quarters and missed market expectations. Management pointed to tighter budgets from major advertisers as a key factor behind the shortfall. The CEO highlighted that growth is increasingly coming from smaller, challenger and ecommerce focused brands, along with international markets. This shift in revenue mix raised fresh questions about Trade Desk’s reliance on large legacy advertisers and its...

Serve Robotics stock just dropped 10% today, yet the real shock is not the share price. The reset in full year revenue guidance to US$9 to 10 million, down sharply from US$26 million, is what is driving the sentiment break. A quarterly revenue line of US$3.2 million now sits against a Q2 net loss of US$64 million, which is a wide gap for any growth story. For investors, today is less about robots and more about trust in the economic model. The market is asking whether this guidance reset is a...

National HealthCare stock slipped about 3% today to US$212.72, even though the latest quarter showed profit power that long term holders will likely care more about than a single red day on the screen. Earnings per share in Q2 came in at US$2.58 on revenue of US$408.03m, backing up a trailing net profit margin of 9% and a P/E of 24x that still sits just under healthcare peers. The headline is simple: the price is cooling in the short term while the earnings base and valuation case remain the...

Delcath Systems stock slipped 2.3% to US$15.11 in the first full session after earnings, yet the quarter itself read more like a quietly confident step forward than a setback. The company delivered Q2 2026 revenue of US$29.1m and moved from recent quarterly losses to a profit of US$2.7m. For a high fixed cost medical equipment business, that swing into the black is the real headline and sets up the rest of the numbers that investors now need to examine more closely. Is Delcath Systems really...

RE/MAX Holdings stock jumped about 5% today, a punchy move for a franchise-heavy real estate brand that has been wrestling with losses. The headline this quarter is simple. The company is still in the red, but the loss narrowed meaningfully compared with the prior quarter, and that is what the market is latching onto. Short term traders are reacting to the bounce. Longer term investors are weighing a different question: Can a business with trailing losses and pressure on interest coverage...

Earnings Beat on Revenue, Pressure on Profitability U.S. Physical Therapy (USPH) reported second quarter 2026 results that combined higher revenue with weaker profitability. Revenue slightly surpassed analyst expectations, while earnings per share came in below forecasts and declined compared to the prior year. For the quarter ended June 30, 2026, revenue was reported at $214.06 million, compared with $197.34 million a year earlier. Net income was $9.9 million versus $12.39 million in the...

In early August 2026, Teradata Corporation reported second-quarter 2026 results showing higher sales of US$363 million, revenue of US$410 million, sharply improved net income of US$46 million, and raised full-year GAAP diluted EPS guidance to a range of US$4.43 to US$4.51. At the same time, Teradata expanded its board with the appointment of technology veteran Bernd Leukert and broadened its AI-focused product reach by launching its enterprise-grade Data Analyst Agent on Amazon Web Services...

Vertex Pharmaceuticals stock has delivered a strong 155.4% return over the past 5 years, yet the current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to some upside while the broader checks look less supportive. Over 5 years, Vertex Pharmaceuticals has returned 155.4%, which puts recent pricing against a backdrop of already strong gains. Expectations around new therapies and pipeline catalysts may support the current share price, while...

Event driven look at Jones Lang LaSalle stock Jones Lang LaSalle (JLL) is back on investors radar after its latest quarterly update showed higher sales and net income for both the second quarter and first half of 2026. See our latest analysis for Jones Lang LaSalle. At a share price of $362.38, Jones Lang LaSalle has a 30 day share price return of 11.84% and a 90 day share price return of 9.86%, while the 1 year total shareholder return of 30.25% and 3 year total shareholder return of 107.76%...

Devon Energy stock has almost doubled investors' money over the past five years, yet the market still prices it on metrics that screen as undervalued and the broader valuation checks lean supportive rather than stretched. Devon Energy has returned 96.5% over five years, which keeps the stock in focus for investors who want to know if the current price still leaves room for attractive risk adjusted returns. The recent merger with Coterra and higher production plans can support expectations...

Why Marvell Technology Stock Is Back in Focus After New AI Memory Launch Marvell Technology (MRVL) is back on investors’ radar after unveiling a broad AI memory infrastructure lineup that targets hyperscalers and cloud providers looking to scale large model inference more efficiently. The new portfolio covers server level storage, rack scale CXL memory expansion and an optical shared memory tier designed to support heavier AI inference workloads. For shareholders, the announcement raises...

In early August 2026, Broadridge Financial Solutions reported higher fourth-quarter and full-year earnings, approved a 12% annual dividend increase to US$4.36 per share, launched a new US$1.50 billion share repurchase program, and expanded its unified governance platform to support proxy voting for tokenized equities via Payward Services’ xStocks framework. Together, these moves highlight Broadridge’s push to link traditional proxy infrastructure with blockchain-based securities while...

HCI Group stock came into this earnings season already on a tear, with a 90 day return of about 24%. The market liked what it saw again. Shares jumped another 4.3% to US$188.69 in the first full session after results. The headline is not just another solid quarter. HCI Group delivered Q2 pretax income of more than US$110m and kept its combined ratio near 61%, which is unusually low for a catastrophe exposed insurer. That mix of strong underwriting profitability and growing premium volume is...

Alkermes earnings update and new guidance Alkermes (NasdaqGS:ALKS) stock is in focus after the company reported second quarter 2026 results, issued third quarter and full year earnings guidance that points to a GAAP net loss, and filed a new shelf registration. The fresh information gives you several moving parts to weigh. Revenue, profitability guidance, previous share repurchases and potential future ordinary share issuance can all affect how you think about Alkermes as an investment...

Strategy Inc (NasdaqGS:MSTR) has launched a Bitcoin-backed preferred stock structure that it says was designed with input from ChatGPT. The new preferred shares are backed by the company’s Bitcoin holdings and are part of a broader move to build a fresh business model around digital assets. Strategy reports raising US$15b through this preferred stock offering, with management positioning the structure as a capital flywheel for future growth initiatives. The company is publicly targeting a...

Capri Holdings (CPRI) stock is back in focus after first quarter earnings on August 5, 2026, reported higher net income and EPS on slightly lower sales, along with detailed revenue and profit guidance. See our latest analysis for Capri Holdings. The Capri Holdings share price closed at US$15.31 on August 6, 2026, and despite a 1 day share price return of 2.07% after the earnings release, momentum has been weak with the 30 day share price return down 14.47% and the 1 year total shareholder...

Calumet, Inc. reported past second-quarter 2026 results with sales of US$1,445.1 million versus US$1,026.6 million a year earlier, and a net loss of US$95.9 million versus US$147.9 million, alongside wider six‑month losses despite higher year‑to‑date sales. The combination of stronger quarterly revenue, a smaller quarterly loss, and a larger year‑to‑date loss gives investors a mixed picture of Calumet’s progress on profitability and operational momentum. Next, we’ll examine how higher...

Freeport McMoRan stock added 2.1% to close at US$69.61, a calm move for a miner that just put a sharp earnings step up on the tape. The headline is simple. Q2 basic earnings per share came in at US$0.68 on revenue of US$7,029m, with net income of US$984m. That profit line now sits well ahead of recent quarters and frames a company leaning hard into copper, gold and molybdenum production. The market reaction looks measured rather than euphoric. Investors are treating this quarter as...

AvePoint stock barely flinched after earnings, slipping 0.2% to US$12.77, yet the quarter itself looked far more energetic than the share price. Revenue came in at US$124.5m and basic earnings per share reached US$0.13, both reinforcing the company’s move into consistent profitability. For a software company selling governance and security tools for cloud and artificial intelligence workloads, the real headline was the 27% year on year growth in software as a service revenue and strong annual...

Blend Labs stock just dropped 16% to about US$1.63, even though the company reported one of its cleanest profit stories yet. Q2 revenue landed at US$33.8m and non GAAP operating income reached US$7m, with a 20.6% margin and free cash flow of US$6.9m. The immediate concern is the cautious guidance on loan volumes and the reminder that revenue growth is expected to trail the broader US market. The longer term question for investors is whether a still unprofitable software platform with a rising...

International Seaways (INSW) has drawn investor attention after a strong year-to-date share move, with the stock up 96.7% in 2026. That performance contrasts with more subdued recent trading. See our latest analysis for International Seaways. Short term momentum for International Seaways has cooled, with the share price slipping 0.9% over the past day and 3.9% over the past week. Even so, its year to date share price return of 96.7% and very large 5 year total shareholder return point to a...

The Trump administration’s push to remove Federal Reserve governor Lisa Cook has pulled interest rate politics back into the spotlight and put the focus squarely on stocks that react most when borrowing costs change. For investors, that mix of policy risk and dividend income can feel like both a warning light and an opening. This article walks through three large, income focused stocks that appear especially exposed to these latest Fed headlines. The three stocks that follow are only a...

Omada Health just jumped 21.2% in a single session, and that move highlights how sharply expectations have flipped. A stock that had been grinding higher over the past quarter suddenly traded like a high growth software winner following its Q2 report. The headline is simple. Omada Health reported roughly US$88 million in revenue and about US$5.3 million in net income, its second straight quarter in the black. For a digital health company long treated as a scale first, profits later story,...